Kymera Therapeutics, Inc. ($KYMR)
Filing Information
| Accession Number | 0000921895-26-001688 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 26, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
1,630,658
Total Value
$173,665,077.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock, $0.0001 par value | โ | Jun 26, 2026 | Sale | 837,914 | $106.50 | $89,237,841.00 | 1,960,881 | Direct | โ | View Details | |
Director | Common Stock, $0.0001 par value | โ | Jun 26, 2026 | Sale | 627,597 | $106.50 | $66,839,080.50 | 1,592,261 | Direct | โ | View Details | |
Director | Common Stock, $0.0001 par value | โ | Jun 26, 2026 | Sale | 113,289 | $106.50 | $12,065,278.50 | 240,123 | Direct | โ | View Details | |
Director | Common Stock, $0.0001 par value | โ | Jun 26, 2026 | Sale | 51,858 | $106.50 | $5,522,877.00 | 78,787 | Indirect | See footnote | View Details |